Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CE9C9 | IM / RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 3273H | IM / LA |
Found out right after patient left that the antigen component of Arexvy was expired on 7/6/25 (administered on 7/15/25). Checked with patient that she is not experiencing any unusual side effects other than sore arms. Patient will return to pharmacy for revaccination as recommended by the CDC.